Oct. 3 at 6:31 PM
$CPSH The real specialist's giving info about this overvalued Company:
Risks / red flags CPSH
1. Unprofitable historically / negative free cash flow
Over the past 12 months, CPSH is unprofitable (net loss ~
$1.84M).
Operating and free cash flows are negative (operating: –
$3.16M; free cash flow: –
$3.61M).
Because of this, valuation is hard to pin down using traditional P/E metrics. Many models flag it as “below fair value” or “insufficient data” to reliably value.
2. Valuation models suggest potential overvaluation
A DCF-based intrinsic value estimate places CPSH at ~
$0.52, which is far below the current trading price. That model suggests it may be overvalued by ~86 %.
WallStreetZen’s valuation suggests a “fair value” of ~
$0.37 and considers the current price heavily overvalued (~900+ % over) under its DCF modeling assumptions.
